Are NMDA and opioid receptors involved in the antidepressant actions of ketamine?
- 19 May 2020
- journal article
- letter
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (21) , 11200-11201
Abstract
No abstract availableFunding Information
- Japan Agency for Medical Research and Development (JP19dm0107119)
This publication has 10 references indexed in Scilit:
- Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodentsProceedings of the National Academy of Sciences, 2020
- Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolitesTranslational Psychiatry, 2019
- Abnormal composition of gut microbiota is associated with resilience versus susceptibility to inescapable electric stressTranslational Psychiatry, 2019
- Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonismMolecular Psychiatry, 2019
- Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspectivePsychiatry and Clinical Neurosciences, 2019
- Ketamine: A Paradigm Shift for Depression Research and TreatmentNeuron, 2019
- Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case series of Patients With Depression and Alcohol Use DisorderJAMA Psychiatry, 2019
- Lack of Opioid System in the Antidepressant Actions of KetamineBiological Psychiatry, 2019
- Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor AntagonismAmerican Journal of Psychiatry, 2018
- The recent progress in animal models of depressionProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2017